Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.
McGurnaghan SJ, Brierley L, Caparrotta TM, McKeigue PM, Blackbourn LAK, Wild SH, Leese GP, McCrimmon RJ, McKnight JA, Pearson ER, Petrie JR, Sattar N, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group. McGurnaghan SJ, et al. Among authors: colhoun hm. Diabetologia. 2019 Apr;62(4):621-632. doi: 10.1007/s00125-018-4806-9. Epub 2019 Jan 10. Diabetologia. 2019. PMID: 30631892 Free article.
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
O'Reilly JE, Blackbourn LAK, Caparrotta TM, Jeyam A, Kennon B, Leese GP, Lindsay RS, McCrimmon RJ, McGurnaghan SJ, McKeigue PM, McKnight JA, Petrie JR, Philip S, Sattar N, Wild SH, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group. O'Reilly JE, et al. Among authors: colhoun hm. Diabetologia. 2020 Aug;63(8):1626-1636. doi: 10.1007/s00125-020-05173-w. Epub 2020 May 26. Diabetologia. 2020. PMID: 32451572 Free PMC article.
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
Caparrotta TM, Blackbourn LAK, McGurnaghan SJ, Chalmers J, Lindsay R, McCrimmon R, McKnight J, Wild S, Petrie JR, Philip S, McKeigue PM, Webb DJ, Sattar N, Colhoun HM; Scottish Diabetes Research Network–Epidemiology Group. Caparrotta TM, et al. Among authors: colhoun hm. Diabetes Care. 2020 Sep;43(9):2034-2041. doi: 10.2337/dc20-0120. Epub 2020 Jun 24. Diabetes Care. 2020. PMID: 32581068 Free article.
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
McKeigue PM, Weir A, Bishop J, McGurnaghan SJ, Kennedy S, McAllister D, Robertson C, Wood R, Lone N, Murray J, Caparrotta TM, Smith-Palmer A, Goldberg D, McMenamin J, Ramsay C, Hutchinson S, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group. McKeigue PM, et al. Among authors: colhoun hm. PLoS Med. 2020 Oct 20;17(10):e1003374. doi: 10.1371/journal.pmed.1003374. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33079969 Free PMC article.
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O'Reilly JE, Wild SH, Hatam S, Höhn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group. McGurnaghan SJ, et al. Among authors: colhoun hm. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. doi: 10.1016/S2213-8587(20)30405-8. Epub 2020 Dec 23. Lancet Diabetes Endocrinol. 2021. PMID: 33357491 Free PMC article. Clinical Trial.
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Höhn A, Jeyam A, Caparrotta TM, McGurnaghan SJ, O'Reilly JE, Blackbourn LAK, McCrimmon RJ, Leese GP, McKnight JA, Kennon B, Lindsay RS, Sattar N, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group. Höhn A, et al. Among authors: colhoun hm. Diabetologia. 2021 Jun;64(6):1309-1319. doi: 10.1007/s00125-021-05394-7. Epub 2021 Feb 19. Diabetologia. 2021. PMID: 33608768 Free PMC article.
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
McKeigue PM, Kennedy S, Weir A, Bishop J, McGurnaghan SJ, McAllister D, Robertson C, Wood R, Lone N, Murray J, Caparrotta TM, Smith-Palmer A, Goldberg D, McMenamin J, Guthrie B, Hutchinson S, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group. McKeigue PM, et al. Among authors: colhoun hm. BMC Med. 2021 Feb 22;19(1):51. doi: 10.1186/s12916-021-01907-8. BMC Med. 2021. PMID: 33612113 Free PMC article.
Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies.
Caparrotta TM, Greenhalgh AM, Osinski K, Gifford RM, Moser S, Wild SH, Reynolds RM, Webb DJ, Colhoun HM. Caparrotta TM, et al. Among authors: colhoun hm. Diabetes Ther. 2021 Apr;12(4):991-1028. doi: 10.1007/s13300-021-01004-2. Epub 2021 Mar 4. Diabetes Ther. 2021. PMID: 33665777 Free PMC article. Review.
250 results